The emerging use of platelet-rich plasma in musculoskeletal medicine

Jamil Bashir, Alberto J Panero, Andrew L. Sherman

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Platelet-rich plasma (PRP) is one of many new developments within the expanding field of regenerative medicine. Specialists in areas such as orthopedics, physical medicine and rehabilitation, and rheumatology have been exploring the benefits of this novel therapy. Although PRP therapy remains controversial and has minimal clinical trial support, the use of orthobiologics such as PRP continues to advance as patients seek nonsurgical approaches to acute and chronic musculoskeletal injury and disease. However, academic acceptance as well as insurance reimbursement remain reliant on solid and repeatable positive results from large clinical trials. The authors summarize the evolution of PRP therapy and report on its status.

Original languageEnglish (US)
Pages (from-to)24-31
Number of pages8
JournalJournal of the American Osteopathic Association
Volume115
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Platelet-Rich Plasma
Medicine
Clinical Trials
Musculoskeletal Diseases
Physical and Rehabilitation Medicine
Regenerative Medicine
Rheumatology
Insurance
Orthopedics
Therapeutics
Wounds and Injuries

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

The emerging use of platelet-rich plasma in musculoskeletal medicine. / Bashir, Jamil; Panero, Alberto J; Sherman, Andrew L.

In: Journal of the American Osteopathic Association, Vol. 115, No. 1, 01.01.2015, p. 24-31.

Research output: Contribution to journalReview article

@article{0285b555aa364397907adccf12834d91,
title = "The emerging use of platelet-rich plasma in musculoskeletal medicine",
abstract = "Platelet-rich plasma (PRP) is one of many new developments within the expanding field of regenerative medicine. Specialists in areas such as orthopedics, physical medicine and rehabilitation, and rheumatology have been exploring the benefits of this novel therapy. Although PRP therapy remains controversial and has minimal clinical trial support, the use of orthobiologics such as PRP continues to advance as patients seek nonsurgical approaches to acute and chronic musculoskeletal injury and disease. However, academic acceptance as well as insurance reimbursement remain reliant on solid and repeatable positive results from large clinical trials. The authors summarize the evolution of PRP therapy and report on its status.",
author = "Jamil Bashir and Panero, {Alberto J} and Sherman, {Andrew L.}",
year = "2015",
month = "1",
day = "1",
doi = "10.7556/jaoa.2015.004",
language = "English (US)",
volume = "115",
pages = "24--31",
journal = "The Journal of the American Osteopathic Association",
issn = "0098-6151",
publisher = "American Osteopathic Association",
number = "1",

}

TY - JOUR

T1 - The emerging use of platelet-rich plasma in musculoskeletal medicine

AU - Bashir, Jamil

AU - Panero, Alberto J

AU - Sherman, Andrew L.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Platelet-rich plasma (PRP) is one of many new developments within the expanding field of regenerative medicine. Specialists in areas such as orthopedics, physical medicine and rehabilitation, and rheumatology have been exploring the benefits of this novel therapy. Although PRP therapy remains controversial and has minimal clinical trial support, the use of orthobiologics such as PRP continues to advance as patients seek nonsurgical approaches to acute and chronic musculoskeletal injury and disease. However, academic acceptance as well as insurance reimbursement remain reliant on solid and repeatable positive results from large clinical trials. The authors summarize the evolution of PRP therapy and report on its status.

AB - Platelet-rich plasma (PRP) is one of many new developments within the expanding field of regenerative medicine. Specialists in areas such as orthopedics, physical medicine and rehabilitation, and rheumatology have been exploring the benefits of this novel therapy. Although PRP therapy remains controversial and has minimal clinical trial support, the use of orthobiologics such as PRP continues to advance as patients seek nonsurgical approaches to acute and chronic musculoskeletal injury and disease. However, academic acceptance as well as insurance reimbursement remain reliant on solid and repeatable positive results from large clinical trials. The authors summarize the evolution of PRP therapy and report on its status.

UR - http://www.scopus.com/inward/record.url?scp=84923331044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923331044&partnerID=8YFLogxK

U2 - 10.7556/jaoa.2015.004

DO - 10.7556/jaoa.2015.004

M3 - Review article

C2 - 25550489

AN - SCOPUS:84923331044

VL - 115

SP - 24

EP - 31

JO - The Journal of the American Osteopathic Association

JF - The Journal of the American Osteopathic Association

SN - 0098-6151

IS - 1

ER -